Archives
2010: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2009: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2008: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2007: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2006: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2005: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2004: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2003: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2002: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
September 2010
- Drug Patent Challenge Report profiles companies that successfully challenged pharmaceutical drugs
- Orphan Drug Exclusivity profiles FDA-approved Orphan Drugs
- Cole-Parmer Introduces APEX 100 Metal Detectors from Thermo Scientific
- Deadline Nears for the Largest Drug Safety Summit held in the Western...
- Intrinsic Imaging Appoints Jatinder Kaur as Senior Director, Medical...
- Drug Patent Expirations in September 2010
- Drug Patent Expirations in September 2010
- Sacramento Law Firm Scrutinizes Johnson & Johnson Again, as the...
- Syngenta Strengthens U.S. Wheat Herbicide Portfolio with Development...
- New Guide Explores How to Recycle Carbon Emissions into Green Fuel
- Orbital Technologies Corporation (ORBITEC) Helps NASA Grow Vegetables...
August 2010
- Brinks Announces 2010 Innovation Competition Finalists
- Brinks Announces 2010 Innovation Competition Finalists
- Therapure Biopharma Inc.'s Drug Delivery Program for the Treatment of...
- Digital Pathology Services Firm Flagship Biosciences Creates...
- Orphan Drug Report
- Extech Video Borescope Inspection Cameras New from Cole-Parmer
- Extech Video Borescope Inspection Cameras New from Cole-Parmer
- Extech Video Borescope Inspection Cameras New from Cole-Parmer
- Extech Video Borescope Inspection Cameras New from Cole-Parmer
- Extech Video Borescope Inspection Cameras New from Cole-Parmer
- Johnson & Johnson's DePuy Orthopedics, Inc. Recalls the ASR XL...
- Invida to Participate in Key September Conferences in the U.S.
- Microsonic Systems Enters Asia-Pacific Market
- Putting China in Your Business Future ... Just Got Less Expensive
- Arrowhead Releases New Report Revealing Prospects for Traumatic Brain...
- Agile Sciences awarded NIH SBIR grant to validate biofilm dispersion...
- Medyssey Spine Receives FDA 510(k) Clearance for Zenius(TM)...
- The Workplace Group® Ranked #3 Mid-Market Provider of Recruitment...
- Quincy Bioscience Receives Investment Capital from DaneVest
- CAS Chemistry Research Report: A Decade Later Human Genome Discoveries...
- Novo Nordisk Creates “App” to Help Doctors Dose Insulin, Supporting...
- Bio Bank Helps Lethal Brain Cancer Patient Maintain Tissue Ownership Defy the Odds
- Healthcare Data Solutions Announces Segment Leader for Pharmacy...
- Coming soon - Biotechnology Entrepreneurship: From Science to Solutions
- Interact, Network and Exchange Opinions on Commercialization of...
- Cataract Surgery Goes 3D Hi-Def in Arkansas
- Mayo Clinic Doctors Plant the Seeds of Success in Cancer Surgery
- Synthetic Biology: Revolutionary or Evolutionary
- The Porcine microRNAome is Revealed
- Unigen Announces the Launch of Bakutrol™ - Powerful Triple-Acting Skin...
- Profile drugs with FDA regulatory exclusivity
- Senior FDA Speakers Discuss Emerging Issues In Cardiovascular Safety...
- Advanced Clinical Announces a Breakthrough Framework to Improve R&D...
- Haydon Kerk Motion Solutions, Inc. Announces New Online Prototype...
- The MedZilla Report for August 2010 - Health Care Job Creation Numbers...
- Broad Institute acquires license to all ChemAxon products and deploys across Chemical Biology Platform.
- Center For Medical Science Chemical Decontamination System
- Center For Medical Science Chemical Decontamination System
- How Genes Hide Their Function
- Undergraduates use Oxford Instruments MARAN Ultra Benchtop NMR...
- Quincy Bioscience Launches Animal Health Division
- UW Scientists Use 3D Cell Culture to Model Breast Cancer in...
- Business Video Site eCorpTV Welcomes Michael A. Colleran as Chairman...
- BiondVax Announces Receipt of Ethics (“Helsinki”) Committee Approvals for the Initiation of first Phase II Clinical Trial for Universal Influenza Vaccine
- Headwaters MB Adds to Life Sciences Team
- Zero Valent Iron for Soil and Water Remediation.
- Second Accelerator to More Than Double E-BEAM Services’ Medical...
- Ariadne, Cellecta and Roswell Park Cancer Institute to Collaborate on...
- Starting from Sand: Manufacturing Quality Labware on a Global Scale...
- Small-molecule Inhibitor Uncovers Protein Role in Melanoma Cell...
- Neumedicines Receives $2.5 Million from HHS/BARDA After Successful...
- Drug inventor report profiles individuals, US states, and countries leading pharmaceutical innovation
- Glidewell Laboratories Selects Objet Geometries to Offer Complete...
- DIA's Global Approach to Risk Management of Medicines Conference...
- iCardiac Reports Record Revenue Growth
- Pharmaceutical Development Services (PDS) and Schiff & Company Form...
- Healthcare Regulatory Professionals More Involved in Business and...
- RURO Launches Sciency ELN 2.0, a New Version of Electronic Lab...
- Improved Drop Setter Instrument for Protein Crystallization
- The University of Toronto Announces Free OpenHelix Tutorial and...
- MD Biosciences Preclinical Efficacy Models of Parkinson's Disease:...
- Experts Review of Chinese Cuvettes Reveals Astounding Results
- Recruiters Note Marked Improvement in the Job Market
- Global Spectrometers and Spectrophoto/Fluorometers Sales to Exceed...
- Duke Realty Unveils Enhanced Brand Identity
- Scientists Clarify Structural Sasis For Biosynthesis of Mysterious...
- International Hydroponics Expert Uses Pioneering New Hydroponics...
- Media Advisory: 21st International Symposium on Human Identification...
- RURO Announces Release of Sciency® 2.0 Standard Edition
- ion eXtra™ Trial Demonstrates that Electrolyte Balancing is the Way...
- Filter Testing - Understanding Filter Efficiency and Standards
- Green Wastewater Treatment Technology Secures $2 Million Investment
- Biomass Pellets Trade Asia, a Buyers and Sellers Meet, Explores...
- Solixia Receives National Cancer Institute SBIR Award
- New Binaural Technology from PranaHigh Eliminates the Need for...
- Who are the leading drug innovators, and where do they live?
- Drug Patent Expirations in August 2010
July 2010
- Synthetic Biology: What's the Agenda?
- Biotechnology and Business Publishing Opportunities: Blog posts, Journal Articles, Books, and Magazines
- Journal of Commercial Biotechnology -- July 2010 issue now available
- Building the Case for Biotechnology: Management Case Studies in Science, Laws, Regulations, Politics, and Business
- Biotech U -- Free online biotechnology course
- Drug Patent Expirations in July 2010
June 2010
- Biosimilar drugs to gain greater priority as decade progresses
- Biotechnology Management Papers, 2010
- Profitability and Orphans: The Role of Price and Incentives in Four Different Markets
- If You Build It, Will They Come?
- Patent Analysis: A Tool for Making Strategic Business Decisions
- Drug Patent Expirations in June 2010
- Coming soon: Building the case for biotechnology
May 2010
- Guest post: Healthcare Reform Bill Presents Significant Opportunity for Life Science Companies Engaged in Innovative Research
- Scientific American WorldView 2010: Measuring global biotechnology innovation
- Free access to the Journal of Commercial Biotechnology
- Get to Market Now! Turn FDA Compliance into a Competitive Edge in the Era of Personalized Medicine
- 2010 Biotech Humanitarian Award goes to Robert Klein
- Scientific American Worldview rollout -- 3pm today
- Celebrating my (dissertation) independence day
- Booksigning at BIO 2010
- BIO2010 Day 2: Meetings
- Scientific American Worldview -- Measuring biotechnology innovation
- First day at BIO -- Getting Settled
- Drug Patent Expirations in May 2010
- Blogging from BIO2010
April 2010
- Journal of Commercial Biotechnology -- April 2010 issue now available
- Case studies in innovation: What enables outstanding achievements?
- Fulfilling Market Needs for Success in Biotechnology
- Next DCbiotech meeting: April 14th in Bethesda, with special guest
- Drug Patent Expirations in April 2010
March 2010
- Maryland Incubator Company of the Year Award Deadline Extended
- Coming soon - Get to Market Now!
- Do you work in biotechnology? Live in the DC area? Join DC Biotech!
- Educating the Next Generation of Biotechnology Managers and Founders
- Drug Patent Expirations in March 2010
February 2010
- My picks for the Biotech Humantarian Award
- Educating the Next Generation of Biotechnology Founders and Managers
- Drug Patent Expirations in February 2010
January 2010
- Seeking new editorial board members for the Journal of Commercial Biotechnology
- How do you train your new biotechnology employees?
- Scientific American worldView Interview available
- 2010 Biotech Humanitarian Award
- Journal of Commercial Biotechnology -- January 2010 issue now available
- Drug Patent Expirations in January 2010
December 2009
November 2009
- Drug Patent Expirations in December 2009
- Perspectives on the Kyoto Prize
- Is the practice of medicine impeding medical innovation?
- Drug Patent Expirations in November 2009
October 2009
- Biologic data exclusivity: The arguments for and against it
- Kyoto Prize Journalism Fellowship
- Drug Patent Expirations in October 2009
September 2009
- Journal of Commercial Biotechnology -- October 2009 issue now available
- Pfizer's Power on Individualized Medicine
- Introducing DCbiotech -- High-level networking in the nation's capital
- Drug Patent Expirations in September 2009
August 2009
- Biotechnology green shoots?
- Jim Greenwood on Data Exclusivity and Healthcare Innovation
- The impact of the global financial crisis on biotechnology development
- Drug Patent Expirations in August 2009
July 2009
June 2009
- Journal of Commercial Biotechnology -- July 2009 issue now available
- Innovating Across Borders
- Koronis: Developing a new treatment for HIV
- Drug Patent Expirations in June 2009
May 2009
- Biotechnology Management Papers
- The changing roles of CRO
- Discovering potential drug targets
- Financial opportunities for early stage biotech companies
- Discussing the worldVIEW Project
- Biotech protesters and the economic crisis
- Scientific American WorldVIEW: Measuring Global Biotechnology Innovation
- VC's don't read business plans; So, what to do?
- Measuring Global Biotechnology
- Creative Destruction in Biotechnology
- Drug Patent Expirations in May 2009
April 2009
- Assessing India's Innovation Climate
- An Overview of the Biopharmaceutical Landscape Ahead
- Measuring global biotechnology innovation
- Drug Patent Expirations in April 2009
March 2009
- Will Roche Spin Genentech Off Again?
- Entrepreneurship: What Not to Do
- Journal of Commercial Biotechnology -- April 2009 Special Issue on Education
- Drug Patent Expirations in March 2009
February 2009
- Call for chapters - Biotechnology Marketing
- Drug Development – Balancing National and Commercial Needs
- Biotechnology Certificate Program at JHU's Carey School of Business
- Drug Patent Expirations in February 2009
- Solving the FDA Crisis
January 2009
- The Critical Reasons You Need to Plan Your Business, then Work Your Plan
- Introducing BiotechBistro.com
- 2008 in Review
- Introducing Biotech-U: Web-based courses on biotechnology
- Drug Patent Expirations in January 2009
December 2008
- Journal of Commercial Biotechnology -- January 2009
- Instructor resources for Building Biotechnology
- Biotechnology and the Global Financial Crisis
- Ranking International Biotechnology
- Drug Patent Expirations in December 2008
- Spread your message with BiotechBlog
November 2008
- Join the Journal of Commercial Biotechnology Discussion Group
- Slow Posting -- New Project in the Works
- Drug Patent Expirations in November 2008
October 2008
- Journal of Commercial Biotechnology -- October 2008
- Intellectual Property Theft on the Rise
- Biotechnology Career Development
- Seeking experienced industry insiders for book series
- Drug Patent Expirations in October 2008
September 2008
- When will the U.S. develop concise generic biologic rules?
- Commercializing biotechnology in China
- Drug Patent Expirations in September 2008
August 2008
- Contract research helps keep drug pipeline flowing
- Building Biotechnology 3rd Edition now available
- Beyond the Business Plan: Managing unexpected risk in biotechnology business development
- Drug Patent Expirations in August 2008
July 2008
- Roche and Genentech's mating dance -- This isn't the first time
- Background: The Clinical and Translational Science Awards Consortium (CTSA program)
- Why the market does not like Flurizan
- Advertise on Biotechblog
- Journal of Commercial Biotechnology -- July 2008
- Looking for writers for book projects
- Drug Patent Expirations in July 2008
June 2008
- Dyadic founder regains control
- Six Pitfalls to Avoid in Supplier Management
- Reminder: BIO2008 Session
- Reminder: BIO2008 book signing
- Drug Patent Expirations in June 2008
- Seeing the Field
May 2008
- Promote your expertise
- Call for papers: Biotechnology Investing
- BIO2008 book signing
- Seeking reviewers and contributors for next edition of Building Biotechnology
- Dyadic founder fights to regain control of company
- Drug Patent Expirations in May 2008
April 2008
- Why so quiet?
- Journal of Commercial Biotechnology -- March 2008
- Drug Patent Expirations in April 2008
March 2008
- Upcoming talks
- New Biotechnology Books on Biotechnology Business Development and Biotechnology Education
- Drug Patent Expirations in March 2008
February 2008
- Generic Biologics: How to Compete
- BIO's website hacked?
- Upcoming talk: Forget everything you thought you knew about biotechnology entrepreneurship
- An appeal for generic biologic legislation
- Drug Patent Expirations in February 2008
January 2008
- New Biotechnology Books
- Want biotechnology venture capital? Use a shotgun!
- Journal of Commercial Biotechnology - Free Issue!
- Drug Patent Expirations in January 2008
December 2007
November 2007
- Venture Capital Returns
- Call for Papers: Biotechnology Marketing
- Career Development in Biotechnology
- Rethink PCR
- Drug Patent Expirations in November 2007
October 2007
- Happy 25th, Humulin
- Exubera: The road to hell is paved with good intentions
- Biotech for Turkey
- Journal of Commercial Biotechnology
- Pharma to support the international space station?
- Drug Patent Expirations in October 2007
September 2007
- Manufacturing is dead. Long live manufacturing!
- Upcoming events
- Building Biotechnology on Facebook
- Drug Patent Expirations in September 2007
August 2007
- Amgen's patents protect Epogen. Again.
- Drug approvals fall. Who's to blame?
- Carnival of Biotechnology
- Journal of Commercial Biotechnology
- Call for chapters: Best practices in biotechnology business development
- Drug Patent Expirations in August 2007
- Carnival of Biotechnology
July 2007
- Expanding the bandwidth of life science investments: Increasing investment viability
- Call for Papers: Journal of Commercial Biotechnology
- Offshoring and U.S. Biotech Labor Shortages
- `Til Death Do Us Part, But First, the Pre-Nup: Why CAPA Needs to Evolve
- Drug reimportation: Where are the dead Canadians?
- Starting a biotechnology company to treat a child
- More details on Google Health
- Drug Patent Expirations in July 2007
June 2007
- Carnival of Biotechnology
- Inhalable Insulin: The Future Is Now
- Off to Toronto
- Google's healthcare ambitions -- the ultimate second opinion
- Shuffling off to Buffalo
- Patenting synthetic life
- Indian pharma scientists commanding U.S. wages - in India
- Herbert Boyer
- Functional Overview of the Biotechnology Industry
- Drug Patent Expirations in June 2007
May 2007
- Carnival of Biotechnology
- The global spread of biotechnology
- A new journal in town...
- Career Development at UNC Chapel Hill
- Greenpeace a champion for genetic modification?
- Top five biotechnology blogs
- Indian biotechnology: Full of promise, challenged by patents
- Drug Patent Expirations in May 2007
April 2007
- Tell me about your career
- Update on the price control power struggle
- Biotech 360
- Abbott Gets Tough with Thailand
- Carnival of Biotechnology
- Upcoming Events
- Write a chapter for my book on Advanced Topics in Biotechnology Business Development
- Drug Patent Expirations in April 2007
- Genentech goes offshore
March 2007
- Patent licensees gain more power
- Carnival of Biotechnology
- Xenotourism: Scary Stuff
- The commercial prospects of biogenerics - how much will they save?
- VCs filling biotech funding gap
- Angels filling biotechnology funding gap
- Looking beyond traditional markets
- Price controls and compulsory licensing give buyers more power ... for a price.
- Carnival of Biotechnology
- Why are biogenerics so hard to regulate?
- Drug Patent Expirations in March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
July 2006
May 2006
April 2006
March 2006
February 2006
January 2006
- Free market for biotech patents?
- Will Human Genome Sciences finally be able to manufacture something in its new plant?
December 2005
- ‘Canadian’ pharmacies not actually in Canada…
- Scripps Institute proposes new Florida site for biotech park
- Intellectual Property: Last chance for Europe’s biotech pioneers
November 2005
October 2005
August 2005
July 2005
June 2005
May 2005
- Drug firms don't disclose enough
- Alternative Stem Cell Bill Added to Debate
- Giving The Green Light To Industrial Biotech
- Genentech's Lessons For Big Pharma
April 2005
March 2005
- FDA guidelines to help personalized drug development
- India Proposes End to Patent Drug Copying
- Nearly 50 new biotech medicines in pipeline
February 2005
- Biotech Buyout Binge Continues
- Ad Changes Ahead for Controversial Drugs
- Drug Patent Approvals
- U.N. Calls for Clone Ban
- Will California's Stem Cell Initiative Reap Royalties?
- FDA Plans New Board To Monitor Drug Safety
- More Roadblocks Ahead For Pharma in 2005?
- Genetically Modified IP Launched
- From the laboratory to the investment fund
- Biotech: A Big Future Behind It?
- The State of Stem Cell Research
- The Human Genome, Take Two
January 2005
- Big Pharma's Ails Could Spread To Biotech
- Financial Snapshot For December
- Biotech Foods Without the Fear Factor
- Big Changes for Big Pharma
- Biotechs forced to work harder to fill openings
- Merck Outlines Vioxx Defense
December 2004
November 2004
- Bill Aims to Protect Joint Patents
- Trouble for California Cloning?
- The Murky History of Merck's Vioxx
- Contingency Plans Help Current Merck Crisis
- Reviewing Drug Safety
- The Stem Cell Gold Rush
October 2004
- Financial Snapshot For September 2004
- Biotech: The "safe" drug bet?
- Biotech execs have a sense of humor about elusive profits
- Is That a Pilot in Your Pocket?
- Foresight or folly? Generics firms' foray into NCEs
- How many trillions for a drug miracle?
- State biotech sector no miracle drug for creation of jobs
- Merck: Successor pill safer than Vioxx
- Big pharma's pain could be biotech's gain
- Few Americans Buy Meds Online
- The Waning Of The Blockbuster Drug
- Financial Snapshot For September 2004
- Beleaguered Merck looks to future
September 2004
- FDA Eases Rules on Drug Manufacturing
- Online Extra: "It's a Perfect Storm" for Drugmakers
- "It's a Perfect Storm" for Drugmakers
- Long Trip for Psychedelic Drugs
- Genetically altered grass spreads like wildfire
- How Dublin Keeps Big Pharma Happy
- The Trials of ImClone
- Drug Patent Expirations in September 2004
- The Time Is Right for These Seven Biotechs
August 2004
- Biotech Knockoffs Lure Novartis
- Biotech returning to favor
- Drug firms in United States, Europe move biotech work to India
July 2004
- Singapore Wants You!
- Biotech's Longer Convalescence
- China: how to seize "commanding point" of biotechnology
- Stem-Cell Cash on a Winding Road
- Financial Snapshot For June 2004
- ImClone Hammered as Sales Lag Estimates
June 2004
May 2004
- The Drug Research War
- Biotechs struggle as IPOs find cool reception
- The Health-Care Catastrophe That Won't Happen
- Will U.S. try to circumvent drug firms patent?
- Another gene genie out of the bottle
- Could patients glean stock tips?: Drug trial participants may be insider trading.
- Financial Snapshot For March 2004: Looking Good
April 2004
- Full Steam Ahead
- Money-Back Guarantee On Rx Drugs
- Can the world afford to reject GM foods?
- Are biotech jobs next to go?
- Financial Snapshot For March 2004
- Drug Company Accused of Bribing Doctors
- Has Obesity Met Its Match?
- "Pssst ... Wanna Buy Some Augmentin?"
March 2004
- The 5% Shuffle - How not to get funded
- A Drug Behemoth In The Making?
- Is genetic engineering next doping threat?
- Boy May Force Change in Norway Bio-Ethics Law
- Drug Prices: The Genentech Solution
- Amgen Opens The Secret Curtain
- Biotech uptick moves into March
- And When ImClone's Drug Doesn't Work...
February 2004
- The perilous path of biotech drugs
- Feds to Biotech: No More Fibbing!
- Pfizer Wins One For Sane Patents
- Hospital ventures into stem-cell reimplantation
- Cloning Creates Human Embryos
- Doctors Call for Abbott Boycott on AIDS Price Hike
- FDA a Big Winner In '05 Bush Budget
- Plants to uncover landmines
- Drug may give cells a fresh start
- On thin ice: how the quest for a billion-dollar microbe is running out of control in Earth's last wilderness
- Management issues challenge biotech startups
- Monsanto: Ready to Blossom?
January 2004
- FDA big factor behind high US drug costs
- FDA Begins Push to End Drug Imports
- What To Expect From A Venture Capitalist
- Is ImClone Out of the Woods?
- What's in a Drug Name?
- Rise in biotech lawsuits
- Agriculture Department looks at revamping biotech rules
- Making Way for Designer Insects
- Biotech firms urge Canada to uphold canola patent
- Biotech Limits Found Lacking
- FDA's economist in chief
- Biotech IPOs; don't let the numbers deceive
- Purple Haze
- Financial Snapshot For December 2003
- What's Next for Pharma?
- India: Big Pharma's New Promised Land?
- Genetically engineered Glofish spark controversy
- Feeling Lucky?
- Biotech industry raises $16.4B in new funding in 2003
- Baby Steps
December 2003
- A Happy Pill for Some Biotechs
- Biotech: A Coming Boom -- or Bust?
- Biotech may be poised for "big year"
- Got Life?
- When Patents Persist
- Amgen's Cannibalistic Ways
- FDA Chief Eyes Path for Copycat Biotech Drugs
- Boston's Biotech Moment
- Professor, Biotech Butt Heads
- Tech Transfer: The Ties That Bind
- Drug companies make patent concessions
- Dutch Official Calls on Europe to Open Markets to Biotech Foods
- Financial Snapshot For November 2003
- A dietary magic bullet?
- FDA, Industry Collaborate On Genomics Guide
- Canola Case Tests GMO Patent
- Food Biotech Is Risky Business
November 2003
- NBI On Drugs
- Glowing red GM fish to sell in US
- Slowdown casts doubt on biotech offerings
- Machine Could Sequence Human Genome in a Year
- Biotech Raises More Cash in 2003 But Europe Weak
- Is That Daylight for ImClone?
- Over the Rainbow Yet?
- Ultimate Analysis
- COUNTERING COUNTERFEITS
- BAYER CHEMICALS TO TAKE A SPIN
- BIOTECH SCORES BIG THIRD-QUARTER GAINS
- DRUG EARNINGS RALLY IN THE THIRD QUARTER
- It Lives for 29 Years?
- Big pharma plays hard ball with little biotech
- USDA Sued Over Drug-Growing Crops
- Staffing needs seen in biotech industry
- Getting Investors' Pulses Beating Again
- Financial Snapshot For October 2003
- Vatican steps in on biotech foods debate
- A survey of strategic licensing practices in the pharmaceutical industry
- The Generic Retribution
- October sees a frenzy of biotech IPOs
- Venture Financing: Ready To Rebound?
- Analyzing Brand-name and Generic Drug Costs in the U.S. and Eight Other Countries
- Gene Tests? Not So Fast
- States flock to biotech like gamblers to lottery tickets
October 2003
- In Initial Finding, FDA Calls Cloned Animals Safe as Food
- Biotech Startups: Take Your Time
- Has the debate on GM crops been misleading?
- Are Adult Stem Cells a Bust?
- Is the US pharmaceuticals industry losing its way?
- U.S. drug companies curb supplies to Canadian exporters
- The next big thing is...
- Pharmaceutical Makers Turn To CRM
- Fog Begins to Lift with Q3 Biotech Numbers
- India emerges as new drug trial hot spot
- Who's Going To Pay For Global Health?
- Seeking a Prescription for Biogenerics
- Why Merck Missed the Mark
- Biotech: Teva's Next Triumph?
- Gene Therapy Rebuilds Gums
- Is Viagra Vulnerable?
- It's Wake-Up Time
- Biotech plans: Boon or fantasy?
- REDISCOVERING NATURAL PRODUCTS
- Biotech funding on track to bounce back
- Popping a pill could fix gene defect
- Monsanto Overhauling Businesses
- Cloning Remains a Meaty Issue
- Sabotage of biotech firms grows
- High hopes for biotech companies / IPOs getting ready to go as startups woo VC investors
- Reducing Multi-Cycle Reviews Is FDA Priority
- Reaping and Sewing From Corn
- Enigmatic ImClone
- IPO market abuzz with biotech offerings
- IPO Market Abuzz with Biotech Offerings
- GE's Genomic Future
- Financial Snapshot For September 2003
- Medicine's Big Bottleneck
- Stem cell bill eyed as lure to biotech firms
- What's Really Banging Up Biovail?
- European biotech - surviving the storm
- Pharma marketing's changing skills set
- Create Competition In Expanding Biotech Field
- Bacteria Make More Electricity
- Geneticists hunt control patterns
- Faster Entry Sought for Generics
- Biotech IPO Pipeline Fills Up
- Financing On Target For A Stellar Year
- GM crops in Brazi
- Affymetrix sells new gene chip / Chip represents full human genome
- Wound drug 'could speed healing'
- Genentech Will Ride Out Drug Failure
September 2003
- Genentech's CEO on Big Pharma's Issues
- FDA's McClellan Calls for More Sharing of Drug R&D Costs
- Drug Development, Genentech Style
- BIOTECH THAWS OUT
- Suit targets 13 generic drug makers
- Judge Allows Antitrust Case Against Seed Producers
- Definitions Impede Stem-Cell Work
- Bioterror Brain Drain
- A dose of reality
- Naturally blonde, brunette...
- Venter Announces $500K Prize for Significant Advances Toward $1,000 Genome
- The Odd Couple - CombinatoRx brings matchmaking to drug discovery and development
- GlaxoSmithKline Reveals Ingenuity
- The Best in Drugs and Biotech
- What VCs Don't Tell You
- Building a Better R&D Mousetrap
- A WTO deal on drugs
August 2003
- Biotechs big winners in VC rebound
- Vatican in favour of GM Food
- Genetically engineered trees sprouting quietly... for now
July 2003
- Antibiotics, The Next Generation
- The War against 'Viagra'
- BIO leader hits proposal for drug price regulation
- Biotech industry in survival mode
- The genetically-modified food fight
- No simple generic answer
- Antibacterials: a dying trade
- Financial Snapshot For June 2003: Taking A Breather
- Pfizer's Quest to Stay Ahead of the Pack
- Can Your Genomics Work Contribute to Biodefense
June 2003
- Biogen/Idec: still a matter of size
- The State of Biotechnology
- Coffee Plants Can Produce Less Caffeine
- Pfizer's Outlook Improves
- Schering's Dr. Feelbetter?
- FDA approves first nasal mist flu vaccine
- Microsoft loses No. 2 ranking in market value to drug maker
- Report Says More Farmers Don't Follow Biotech Rules
- More regulations for biotech products aren't necessary, FDA says
- Pfizer unveils anti-smoking drug
- New Drug Rules Aim To Speed Generics
- RNAi Firms Stake Their Claims
- More U.S. Investment in Biotech Needed, USAID Chief Says
- Wake Up and Smell the Science
- Biotech Investors: When Will They Ever Learn?
- Drug ads deliver a few side effects
- Biotech Industry Could Turn Profitable This Decade
- Biotech firms eye rally hungrily
- Biotech Stock Report - WOW!
- Schering-Plough: Drugmaker, Heal Thyself
- Geron's the Biotech of the Day
- India 'to approve GM potato'
- Genentech's Next Move
- This Dutchman Is Flying
- GM crops 'good for developing countries'
- BIOTECH RALLIES
- Financial Snapshot For May 2003: Yee Hah
- BIOTECH TEMPERATURE RISES
- Biotech is benign
- Science and Law: Swapping the lab for the law
- Biotech sector keeps surging / Cancer drug news and FDA approvals create optimism
- Early stage biotechnology collaborations
- FDA chief looks to speed diabetes, obesity drugs
- Pfizer sues over counterfeit Lipitor
- The ImClone Story: A Hyped Drug, a Tainted Icon
- Five Hurdles for Biotech
- San DNAgo
- Puncturing The ImClone Hype
September 2002
August 2002
- Looking beyond Patent Expiry
- Modified pigs are transplant 'breakthrough'
- Send in the Clones
- New breed of VCs banking on biotech
- Biology Seeks a Few Good Geeks
- Biotechs on edge as money evaporates
- Making a Run for the Border-For Canadian Prescription Drugs
- Biotech industry seeks control of its destiny
- Singapore's biotech bid
July 2002
- Big Pharma: Getting Too Big for Its Own Good?
- European Patent Office bars human cloning in patent
- Woman carries human clone, group says
- Monoclonal Antibodies Look to a Bright Future
- Genomics Sector Has Fired More Than 1,500 Staff Since January 2001
- Biotech Not Cratering, Just Deflating
- Cuba seeks new drug markets
- Time to Let the Air Out
- FDA rules need tweaking
June 2002
- deCODED?
- Will R&D Make Merck Hot Again?
- Cracking the cancer code
- Report raps drug firms' 'post-approval' studies
- Of Clones and Clowns
- Legal Circumvention
- 5 Big Drug Companies Face R&D Drought
- Informatics Moves to the Head of the Class
- Nanopharmaceuticals Open Up Brand New Field Of Study
- Networked Pharma
- Pharma Financial Squeeze Bodes Ill for Genomics
- DeCode's Genetic Breakthrough Barely Registers
- Celera abandons gene sequencing
- Biotrends
- Where the Biotech Bets Are
- Biotech lobbyists' clout grows in Washington
- Gene Doping Threatens to Transform Sports
May 2002
- FDA Acts To Speed Bioterror Medicines
- A Challenge to Science and Nature
- Life after Venter
- Biotech heads west for VC
- Cloning Bill Bans Abortion Too?
- Biotech Banker Predicts More Meetings But Fewer Attendees
- Faulty Genes Explain Why Cloning Is So Difficult
- Two New Bills Present Challenges to DNA Patentability
- Biotech industry's still waiting to break out
- Rating the Nation's Best and Worst Jobs
- Battling Hunger With Biotechnology
- Motorola shedding biochip biz
April 2002
- Drug makers need a cure for the manufacturing crunch
- Celera Shifts Marketing of Database
- Was the U.S. government cheated on DNA decoder?
- Cultivating Prosperous Partnerships
- Harvesting the Fruits of Plant Genomics
- Pa. uses tobacco settlement to fund biotech
- Biotech stocks show indication of rebounding
- Chinese cloning control required
- Veteran biotech investors offer tips from trenches
- Genome Group Rips Human Cloning
- As Pipelines Wither, Pharma and FDA Explore Whether Microarrays are Ready for Primetime
- Research 'leak' hits Genentech
- As Tony White Reads Resumes, Industry Buzzes Around Core Four
- President Presses Senate to Ban All Human Cloning
- 7 drug makers unveil elderly discounts
- Survival of fittest is new mode for biotechs
- Biotech booster shot
- Bad Genes, Good Drugs
- New `greenhouses' to promote biotechnology businesses
- Biotech industry in race for space

![[Bloglines]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/bloglines.png)
![[del.icio.us]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/delicious.png)
![[Digg]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/digg.png)
![[Facebook]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/facebook.png)
![[Google]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/google.png)
![[LinkedIn]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/linkedin.png)
![[Reddit]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/reddit.png)
![[StumbleUpon]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/stumbleupon.png)
![[Twitter]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/twitter.png)
![[Email]](http://www.biotechblog.com/wp-content/plugins/bookmarkify/email.png)









































{ 3 comments… read them below or add one }
just now i subscribed,
i thought that this blog will really give an excellent information. I will be waiting for your latest updates.
Thank you…….
so i am new for this blog and i am here to know about any business plan related to biotech if anybody have any idea plz send me an E.mail
Hi all,
I thought i can get more knowledge on US FDA and Pharma industries.. that is the reason why i registred for this blog..
‘ll see how it works..